Johnson & Johnson Falls Nearly 5% Even After Raising Guidance
Johnson & Johnson shares fell sharply Tuesday even after the healthcare giant beat Wall Street’s third-quarter earnings expectations and raised its full-year outlook, as another disappointing quarter from its MedTech business overshadowed stronger pharmaceutical…